FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / PLoS One / Beneficial effects of autologous bone marrow-derived mesench...
PloS one2013; 8(9); e75697; doi: 10.1371/journal.pone.0075697

Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy.

Abstract: Tendon injuries are a common age-related degenerative condition where current treatment strategies fail to restore functionality and normal quality of life. This disease also occurs naturally in horses, with many similarities to human tendinopathy making it an ideal large animal model for human disease. Regenerative approaches are increasingly used to improve outcome involving mesenchymal stem cells (MSCs), supported by clinical data where injection of autologous bone marrow derived MSCs (BM-MSCs) suspended in marrow supernatant into injured tendons has halved the re-injury rate in racehorses. We hypothesized that stem cell therapy induces a matrix more closely resembling normal tendon than the fibrous scar tissue formed by natural repair. Twelve horses with career-ending naturally-occurring superficial digital flexor tendon injury were allocated randomly to treatment and control groups. 1X10(7) autologous BM-MSCs suspended in 2 ml of marrow supernatant were implanted into the damaged tendon of the treated group. The control group received the same volume of saline. Following a 6 month exercise programme horses were euthanized and tendons assessed for structural stiffness by non-destructive mechanical testing and for morphological and molecular composition. BM-MSC treated tendons exhibited statistically significant improvements in key parameters compared to saline-injected control tendons towards that of normal tendons and those in the contralateral limbs. Specifically, treated tendons had lower structural stiffness (p<0.05) although no significant difference in calculated modulus of elasticity, lower (improved) histological scoring of organisation (p<0.003) and crimp pattern (p<0.05), lower cellularity (p<0.007), DNA content (p<0.05), vascularity (p<0.03), water content (p<0.05), GAG content (p<0.05), and MMP-13 activity (p<0.02). Treatment with autologous MSCs in marrow supernatant therefore provides significant benefits compared to untreated tendon repair in enhancing normalisation of biomechanical, morphological, and compositional parameters. These data in natural disease, with no adverse findings, support the use of this treatment for human tendon injuries.
Get Full Text
Publication Date: 2013-09-25 PubMed ID: 24086616PubMed Central: PMC3783421DOI: 10.1371/journal.pone.0075697Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the use of autologous bone marrow-derived mesenchymal stem cells (BM-MSCs) in treating tendon injuries and reports promising outcomes, showing that the treatment can significantly aid in normalising biomechanical, morphological, and compositional parameters.

Understanding the problem

  • Tendon injuries, as the study notes, are age-related degenerative conditions which are marked by a challenging recovery and a severe impact on the sufferers’ quality of life.
  • The traditional treatment methods often fall short of fully restoring the functionality of the affected areas.
  • The study mentions the occurrence of similar conditions in horses, which makes them an ideal model for studying these diseases.

Regenerative approaches with MSCs

  • Regenerative therapies, particularly the application of mesenchymal stem cells (MSCs), offer some optimism. The effectiveness of MSCs has been corroborated by clinical data that show a significant reduction in the re-injury rate among racehorses treated with MSCs.
  • The researchers speculate that stem cell therapy could lead to the formation of a matrix resembling the normal tendon rather than allowing the fibrous scar tissue produced by the natural repair process to form.

The experimental procedure

  • The scientists worked with horses with career-ending tendon injuries, dividing them into control and experiment groups.
  • The experiment group was treated with autologous BM-MSCs suspended in marrow supernatant, while the control group was given saline instead.
  • After a 6-month exercise period, the horses were euthanized and the tendons assessed for various parameters including structure, morphology and molecular composition.

Observations and conclusions

  • The conclusion was that tendons treated with BM-MSCs demonstrated significant improvement in numerous aspects, edging closer to the characteristics of normal tendons.
  • The parameters that exhibited improved scores included structural stiffness, histological scoring of organisation and crimp pattern, cellularity, DNA content, vascularity, water content, GAG content, and MMP-13 activity.
  • In conclusion, the researchers suggest that the use of autologous MSCs in marrow supernatant allows for substantial benefits towards tendon repair. It aids biomechanical, morphological, and compositional normalization.
  • This indicates that this form of therapy could potentially be effective in treating human tendon injuries.

Cite This Article

APA
Smith RK, Werling NJ, Dakin SG, Alam R, Goodship AE, Dudhia J. (2013). Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy. PLoS One, 8(9), e75697. https://doi.org/10.1371/journal.pone.0075697

Publication

PloS one
ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 8
Issue: 9
Pages: e75697

Researcher Affiliations

Smith, Roger Kenneth Whealands
  • Department of Clinical Sciences and Services, the Royal Veterinary College, University of London, Hatfield, United Kingdom.
Werling, Natalie Jayne
    Dakin, Stephanie Georgina
      Alam, Rafiqul
        Goodship, Allen E
          Dudhia, Jayesh

            MeSH Terms

            • Animals
            • Bone Marrow / physiology
            • Cell- and Tissue-Based Therapy / methods
            • Horse Diseases / physiopathology
            • Horse Diseases / therapy
            • Horses
            • Mesenchymal Stem Cells / physiology
            • Physical Conditioning, Animal / physiology
            • Tendinopathy / physiopathology
            • Tendinopathy / therapy
            • Tendinopathy / veterinary
            • Tendon Injuries / physiopathology
            • Tendon Injuries / therapy
            • Tendon Injuries / veterinary
            • Tendons / physiology
            • Wound Healing / physiology

            Conflict of Interest Statement

            Competing Interests: The authors have the following interests. This study was partly funded by VetCell Bioscience Ltd. RKS was a director of VetCell Bioscience Ltd, UK from 2002 - 2010. There are no patents, products in development or marketed products to declare. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

            References

            This article includes 65 references
            1. http://www.cprd.com The Clinical Practice Research Datalink website. Available: . Accessed 2013 February 10.
            2. nHealth and Social Care Information Centre, Hospital Episode Statisticsnwebsite. Available: nhttp://www.hscic.gov.uk/hes. Accessed 2013 February 10.
            3. Magnussen RA, Dunn WR, Thomson AB. Nonoperative treatment of midportion Achilles tendinopathy: a systematic review. Clin J Sport Med 19: 54-64.
              doi: 10.1097/JSM.0b013e31818ef090pubmed: 19124985google scholar: lookup
            4. Lui PP, Maffulli N, Rolf C, Smith RK. What are the validated animal models for tendinopathy?. Scand J Med Sci Sports 21: 3-17.
              doi: 10.1111/j.1600-0838.2010.01164.xpubmed: 20673247google scholar: lookup
            5. Williams RB, Harkins LS, Hammond CJ, Wood JL. Racehorse injuries, clinical problems and fatalities recorded on British racecourses from flat racing and National Hunt racing during 1996, 1997 and 1998. Equine Vet J 33: 478-486.
              pubmed: 11558743
            6. Avella CS, Ely ER, Verheyen KL, Price JS, Wood JL. Ultrasonographic assessment of the superficial digital flexor tendons of National Hunt racehorses in training over two racing seasons. Equine Vet J 41: 449-454.
              doi: 10.2746/042516409X391042pubmed: 19642404google scholar: lookup
            7. Crevier-Denoix N, Collobert C, Pourcelot P, Denoix JM, Sanaa M. Mechanical properties of pathological equine superficial digital flexor tendons. Equine Vet J Suppl 23-26.
              pubmed: 9354282
            8. Dakin SG, Jespers K, Warner S, O’Hara LK, Dudhia J. The relationship between in vivo limb and in vitro tendon mechanics after injury: a potential novel clinical tool for monitoring tendon repair. Equine Vet J 43: 418-423.
              doi: 10.1111/j.2042-3306.2010.00303.xpubmed: 21496076google scholar: lookup
            9. Wilson AM, McGuigan MP, Su A, van den Bogert AJ. Horses damp the spring in their step. Nature 414: 895-899.
              doi: 10.1038/414895apubmed: 11780059google scholar: lookup
            10. Dyson SJ. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000). Equine Vet J 36: 415-419.
              pubmed: 15253082
            11. Caplan AI. Mesenchymal stem cells. J Orthop Res 9: 641-650.
              doi: 10.1002/jor.1100090504pubmed: 1870029google scholar: lookup
            12. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6: 1282-1286.
              doi: 10.1038/81395pubmed: 11062543google scholar: lookup
            13. Crovace A, Lacitignola L, De Siena R, Rossi G, Francioso E. Cell therapy for tendon repair in horses: an experimental study. Vet Res Commun 31 Suppl 1: 281-283.
              doi: 10.1007/s11259-007-0047-ypubmed: 17682895google scholar: lookup
            14. Vidal MA, Robinson SO, Lopez MJ, Paulsen DB, Borkhsenious O. Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vet Surg 37: 713-724.
              doi: 10.1111/j.1532-950X.2008.00462.xpmc: PMC2746327pubmed: 19121166google scholar: lookup
            15. Vidal MA, Kilroy GE, Lopez MJ, Johnson JR, Moore RM. Characterization of equine adipose tissue-derived stromal cells: adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stromal cells. Vet Surg 36: 613-622.
              doi: 10.1111/j.1532-950X.2007.00313.xpubmed: 17894587google scholar: lookup
            16. Vidal MA, Kilroy GE, Johnson JR, Lopez MJ, Moore RM. Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesenchymal stromal cells: adipogenic and osteogenic capacity. Vet Surg 35: 601-610.
              doi: 10.1111/j.1532-950X.2006.00197.xpubmed: 17026544google scholar: lookup
            17. Strassburg S, Goodship AE, Hardingham TE, Clegg PD. Adult and late foetal equine tendon contain cell populations with weak progenitor properties in comparison to bone marrow derived mesenchymal stem cells. Trans Orthop Res Soc Annu Meet 31: 1113.
            18. Alves AG, Stewart AA, Dudhia J, Kasashima Y, Goodship AE. Cell-based therapies for tendon and ligament injuries. Vet Clin North Am Equine Pract 27: 315-333.
              doi: 10.1016/j.cveq.2011.06.001pubmed: 21872761google scholar: lookup
            19. Fortier LA, Nixon AJ, Williams J, Cable CS. Isolation and chondrocytic differentiation of equine bone marrow-derived mesenchymal stem cells. Am J Vet Res 59: 1182-1187.
              pubmed: 9736400
            20. Schu S, Nosov M, O’Flynn L, Shaw G, Treacy O. Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med 16: 2094-2103.
              doi: 10.1111/j.1582-4934.2011.01509.xpmc: PMC3822979pubmed: 22151542google scholar: lookup
            21. Duffy MM, Pindjakova J, Hanley SA, McCarthy C, Weidhofer GA. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. Eur J Immunol 41: 2840-2851.
              doi: 10.1002/eji.201141499pubmed: 21710489google scholar: lookup
            22. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 16: 406-413.
              doi: 10.1002/jor.1100160403pubmed: 9747780google scholar: lookup
            23. Awad HA, Butler DL, Boivin GP, Smith FN, Malaviya P. Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng 5: 267-277.
              doi: 10.1089/ten.1999.5.267pubmed: 10434073google scholar: lookup
            24. Awad HA, Boivin GP, Dressler MR, Smith FN, Young RG. Repair of patellar tendon injuries using a cell-collagen composite. J Orthop Res 21: 420-431.
              doi: 10.1016/S0736-0266(02)00163-8pubmed: 12706014google scholar: lookup
            25. Hildebrand KA, Jia F, Woo SL. Response of donor and recipient cells after transplantation of cells to the ligament and tendon. Microsc Res Tech 58: 34-38.
              doi: 10.1002/jemt.10114pubmed: 12112420google scholar: lookup
            26. Butler DL, Juncosa-Melvin N, Boivin GP, Galloway MT, Shearn JT. Functional tissue engineering for tendon repair: A multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation. J Orthop Res 26: 1-9.
              doi: 10.1002/jor.20456pubmed: 17676628google scholar: lookup
            27. Ouyang HW, Goh JC, Thambyah A, Teoh SH, Lee EH. Knitted poly-lactide-co-glycolide scaffold loaded with bone marrow stromal cells in repair and regeneration of rabbit Achilles tendon. Tissue Eng 9: 431-439.
              doi: 10.1089/107632703322066615pubmed: 12857411google scholar: lookup
            28. Herthel D. Enhanced suspensory ligament healing in 100 horses by stem cells and other bone marrow components. Proc Am Assoc Equine Practice 47 p. 319.
            29. Smith RK, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J 35: 99-102.
              pubmed: 12553472
            30. Smith JJ, Ross MW, Smith RK. Anabolic effects of acellular bone marrow, platelet rich plasma, and serum on equine suspensory ligament fibroblasts in vitro. Vet Comp Orthop Traumatol 19: 43-47.
              pubmed: 16594543
            31. Schnabel LV, Sonea HO, Jacobson MS, Fortier LA. Effects of platelet rich plasma and acellular bone marrow on gene expression patterns and DNA content of equine suspensory ligament explant cultures. Equine Vet J 40: 260-265.
              doi: 10.2746/042516408X278030pubmed: 18267879google scholar: lookup
            32. Schnabel LV, Lynch ME, van der Meulen MC, Yeager AE, Kornatowski MA. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. J Orthop Res 27: 1392-1398.
              doi: 10.1002/jor.20887pubmed: 19350658google scholar: lookup
            33. Crovace A, Lacitignola L, Rossi G, Francioso E. Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Vetmed Int 2010: 250978.
              pmc: PMC2859019pubmed: 20445779
            34. Schramme M, Hunter S, Campbell N, Blikslager A, Smith R. A surgical tendonitis model in horses: technique, clinical, ultrasonographic and histological characterisation. Vet Comp Orthop Traumatol 23: 231-239.
              doi: 10.3415/VCOT-09-10-0106pubmed: 20585715google scholar: lookup
            35. Caniglia CJ, Schramme MC, Smith RK. The effect of intralesional injection of bone marrow derived mesenchymal stem cells and bone marrow supernatant on collagen fibril size in a surgical model of equine superficial digital flexor tendonitis. Equine Vet J 44: 587-593.
              doi: 10.1111/j.2042-3306.2011.00514.xpubmed: 22150794google scholar: lookup
            36. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Vet J 44: 25-32.
              doi: 10.1111/j.2042-3306.2011.00363.xpubmed: 21615465google scholar: lookup
            37. O’Meara B, Bladon B, Parkin TD, Fraser B, Lischer CJ. An investigation of the relationship between race performance and superficial digital flexor tendonitis in the Thoroughbred racehorse. Equine Vet J 42: 322-326.
              doi: 10.1111/j.2042-3306.2009.00021.xpubmed: 20525050google scholar: lookup
            38. Batson EL, Paramour RJ, Smith TJ, Birch HL, Patterson-Kane JC. Are the material properties and matrix composition of equine flexor and extensor tendons determined by their functions?. Equine Vet J 35: 314-318.
              pubmed: 12755437
            39. Smith RWK. Pathophysiology of tendon injury. In: Ross MW, Dyson S. Diagnosis and Management of Lameness in the Horse. 2nd ed. St. Louis: W.B. Saunders Co..
            40. Dahlgren LA, Mohammed HO, Nixon AJ. Temporal expression of growth factors and matrix molecules in healing tendon lesions. J Orthop Res 23: 84-92.
              doi: 10.1016/j.orthres.2004.05.007pubmed: 15607879google scholar: lookup
            41. Dakin SG, Werling D, Hibbert A, Abayasekara DR, Young NJ. Macrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repair. PLOS ONE 7: e32333.
              doi: 10.1371/journal.pone.0032333pmc: PMC3284560pubmed: 22384219google scholar: lookup
            42. Dakin SG, Dudhia J, Werling NJ, Werling D, Abayasekara DR. Inflamm-aging and arachadonic acid metabolite differences with stage of tendon disease. PLOS ONE 7: e48978.
              doi: 10.1371/journal.pone.0048978pmc: PMC3498370pubmed: 23155437google scholar: lookup
            43. Guest DJ, Smith MR, Allen WR. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study. Equine Vet J 40: 178-181.
              doi: 10.2746/042516408X276942pubmed: 18267891google scholar: lookup
            44. Guest DJ, Smith MR, Allen WR. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon. Equine Vet J 42: 636-642.
              doi: 10.1111/j.2042-3306.2010.00112.xpubmed: 20840579google scholar: lookup
            45. Becerra P, Valdes Vazquez MA, Dudhia J, Fiske-Jackson AR, Neves F. Distribution of injected technetium (99m)-labeled mesenchymal stem cells in horses with naturally occurring tendinopathy. J Orthop Res 31: 1096-1102.
              doi: 10.1002/jor.22338pubmed: 23508674google scholar: lookup
            46. McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res 27: 1033-1042.
              doi: 10.1002/jor.20853pubmed: 19170097google scholar: lookup
            47. Schnabel LV, Mohammed HO, Miller BJ, McDermott WG, Jacobson MS. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 25: 230-240.
              doi: 10.1002/jor.20278pubmed: 17106885google scholar: lookup
            48. Birch HL, Bailey JV, Bailey AJ, Goodship AE. Age-related changes to the molecular and cellular components of equine flexor tendons. Equine Vet J 31: 391-396.
              doi: 10.1111/j.2042-3306.1999.tb03838.xpubmed: 10505954google scholar: lookup
            49. Cadby JA, David F, van de Lest C, Bosch G, van Weeren PR. Further characterisation of an experimental model of tendinopathy in the horse. Equine Vet J 45: 642-648.
              doi: 10.1111/evj.12035pubmed: 23448172google scholar: lookup
            50. Samiric T, Parkinson J, Ilic MZ, Cook J, Feller JA. Changes in the composition of the extracellular matrix in patellar tendinopathy. Matrix Biol 28: 230-236.
              doi: 10.1016/j.matbio.2009.04.001pubmed: 19371780google scholar: lookup
            51. Smith MM, Sakurai G, Smith SM, Young AA, Melrose J. Modulation of aggrecan and ADAMTS expression in ovine tendinopathy induced by altered strain. Arthritis Rheum 58: 1055-1066.
              doi: 10.1002/art.23388pubmed: 18383380google scholar: lookup
            52. Fu SC, Chan KM, Rolf CG. Increased deposition of sulfated glycosaminoglycans in human patellar tendinopathy. Clin J Sport Med 17: 129-134.
              doi: 10.1097/JSM.0b013e318037998fpubmed: 17414481google scholar: lookup
            53. Corps AN, Robinson AH, Movin T, Costa ML, Hazleman BL. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology (Oxf) 45: 291-294.
              pubmed: 16219640
            54. Riley GP, Harrall RL, Constant CR, Chard MD, Cawston TE. Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis 53: 367-376.
              doi: 10.1136/ard.53.6.367pmc: PMC1005351pubmed: 8037495google scholar: lookup
            55. Wang VM, Bell RM, Thakore R, Eyre DR, Galante JO. Murine tendon function is adversely affected by aggrecan accumulation due to the knockout of ADAMTS5. J Orthop Res 30: 620-626.
              doi: 10.1002/jor.21558pubmed: 21928430google scholar: lookup
            56. Corps AN, Robinson AH, Harrall RL, Avery NC, Curry VA. Changes in matrix protein biochemistry and the expression of mRNA encoding matrix proteins and metalloproteinases in posterior tibialis tendinopathy. Ann Rheum Dis 71: 746-752.
              doi: 10.1136/annrheumdis-2011-200391pmc: PMC3329235pubmed: 22241901google scholar: lookup
            57. Plaas A, Sandy JD, Liu H, Diaz MA, Schenkman D. Biochemical identification and immunolocalizaton of aggrecan, ADAMTS5 and inter-alpha-trypsin-inhibitor in equine degenerative suspensory ligament desmitis. J Orthop Res 29: 900-906.
              doi: 10.1002/jor.21332pubmed: 21246622google scholar: lookup
            58. Smith RK, Jones R, Webbon PM. The cross-sectional areas of normal equine digital flexor tendons determined ultrasonographically. Equine Vet J 26: 460-465.
              doi: 10.1111/j.2042-3306.1994.tb04050.xpubmed: 7889919google scholar: lookup
            59. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64: 295-312.
              doi: 10.1002/(SICI)1097-4644(199702)64:2pubmed: 9027589google scholar: lookup
            60. Bancroft JD, Gamble M. Theory and practice of histological techniques. 6th ed. London/GB:. Elsevier Health Sciences.
            61. Barbero A, Ploegert S, Heberer M, Martin I. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum 48: 1315-1325.
              doi: 10.1002/art.10950pubmed: 12746904google scholar: lookup
            62. Young NJ, Becker DL, Fleck RA, Goodship AE, Patterson-Kane JC. Maturational alterations in gap junction expression and associated collagen synthesis in response to tendon function. Matrix Biol 28: 311-323.
              doi: 10.1016/j.matbio.2009.05.002pubmed: 19481603google scholar: lookup
            63. Movin T, Gad A, Reinholt FP, Rolf C. Tendon pathology in long-standing achillodynia. Biopsy findings in 40 patients. Acta Orthop Scand 68: 170-175.
              doi: 10.3109/17453679709004002pubmed: 9174456google scholar: lookup
            64. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883: 173-177.
              doi: 10.1016/0304-4165(86)90306-5pubmed: 3091074google scholar: lookup
            65. Maffulli N, Longo UG, Franceschi F, Rabitti C, Denaro V. Movin and Bonar scores assess the same characteristics of tendon histology. Clin Orthop Relat Res 466: 1605-1611.
              doi: 10.1007/s11999-008-0261-0pmc: PMC2505245pubmed: 18437501google scholar: lookup

            Citations

            This article has been cited 95 times.
            1. Tommasa SD, Raspe S, Farí G, Imperante A, Brehm W. Autologous conditioned serum IRAP efficacy for tendon and ligament injuries in horses: An observational study. Open Vet J 2025;15(8):3787-3793.
              doi: 10.5455/OVJ.2025.v15.i8.43pubmed: 41036008google scholar: lookup
            2. Yuan Z, Yao Z, Mao X, Gao X, Wu S, Mao H. Epigenetic mechanisms in stem cell therapies for achilles tendinopathy. Front Cell Dev Biol 2025;13:1516250.
              doi: 10.3389/fcell.2025.1516250pubmed: 40181824google scholar: lookup
            3. Traweger A, Scott A, Kjaer M, Wezenbeek E, Scattone Silva R, Kennedy JG, Butler JJ, Gomez-Florit M, Gomes ME, Snedeker JG, Dakin SG, Wildemann B. Achilles tendinopathy. Nat Rev Dis Primers 2025 Mar 27;11(1):20.
              doi: 10.1038/s41572-025-00602-9pubmed: 40148342google scholar: lookup
            4. Ortega-Cebrián S, Soler-Rich R, Orozco L, Rodas G. Evaluation of Patellar Tendon Structural Changes following Biological Treatments: Secondary Analysis of Double-Blinded Clinical Trial of Bone Marrow Mesenchymal Stromal Cells and Leukocyte-Poor Platelet-Rich Plasma. Biomedicines 2024 Jul 18;12(7).
              doi: 10.3390/biomedicines12071599pubmed: 39062172google scholar: lookup
            5. Giraldo A, Koch TG, Madan P, Lepage S, Monteith G, Alizadeh AH, Tran A, Mortagy N, Koenig JB. Effect of extracorporeal shockwave therapy on the immunomodulatory and anti-inflammatory properties of cultured equine umbilical cord blood mesenchymal stromal cells. Can J Vet Res 2024 Jul;88(3):87-93.
              pubmed: 38988333
            6. Kusumawardani B, Nurul Amin M, Rahayu YC, Sari DS, Altariq MI, Putri AH, Kanya A, Prahasanti C, Aljunaid MA. Human gingival mesenchymal stem cells-lyosecretome attenuates adverse effect of hydrogen peroxide-induced oxidative stress on osteoblast cells. J Taibah Univ Med Sci 2024 Jun;19(3):687-695.
              doi: 10.1016/j.jtumed.2024.05.002pubmed: 38831997google scholar: lookup
            7. Goldberg AJ, Masci L, O'Donnell P, Green R, Brooking D, Bassett P, Lowdell MW, Smith RKW. Autologous bone marrow derived mesenchymal stem cells are safe for the treatment of Achilles tendinopathy. Sci Rep 2024 May 19;14(1):11421.
              doi: 10.1038/s41598-024-61399-3pubmed: 38763976google scholar: lookup
            8. Koch DW, Froneberger A, Berglund A, Connard S, Souther A, Schnabel LV. IL-1β + TGF-β2 dual-licensed mesenchymal stem cells have reduced major histocompatibility class I expression and positively modulate tenocyte migration, metabolism, and gene expression. J Am Vet Med Assoc 2024 Jun 1;262(S1):S61-S72.
              doi: 10.2460/javma.23.12.0708pubmed: 38547589google scholar: lookup
            9. Eshima K, Ohzono H, Gotoh M, Abe R, Nakamura H, Mitsui Y, Hiraoka K, Okawa T. Effects of adipose-derived cell supplementation on tendon-bone healing in a rat model of chronic rotator cuff tear with suprascapular nerve injury. J Int Med Res 2024 Mar;52(3):3000605241232550.
              doi: 10.1177/03000605241232550pubmed: 38456645google scholar: lookup
            10. Smith EJ, Beaumont RE, Dudhia J, Guest DJ. Equine Embryonic Stem Cell-Derived Tenocytes are Insensitive to a Combination of Inflammatory Cytokines and Have Distinct Molecular Responses Compared to Primary Tenocytes. Stem Cell Rev Rep 2024 May;20(4):1040-1059.
              doi: 10.1007/s12015-024-10693-8pubmed: 38396222google scholar: lookup
            11. Taguchi T, Lopez M, Takawira C. Viable tendon neotissue from adult adipose-derived multipotent stromal cells. Front Bioeng Biotechnol 2023;11:1290693.
              doi: 10.3389/fbioe.2023.1290693pubmed: 38260742google scholar: lookup
            12. Mao XF, Zhang XQ, Yao ZY, Mao HJ. Advances in mesenchymal stem cells therapy for tendinopathies. Chin J Traumatol 2024 Jan;27(1):11-17.
              doi: 10.1016/j.cjtee.2023.11.002pubmed: 38052701google scholar: lookup
            13. Burk J, Wittenberg-Voges L, Schubert S, Horstmeier C, Brehm W, Geburek F. Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses. Cells 2023 Oct 24;12(21).
              doi: 10.3390/cells12212513pubmed: 37947591google scholar: lookup
            14. Tamura N, Heidari N, Faragher RGA, Smith RKW, Dudhia J. Effects of resveratrol and its analogues on the cell cycle of equine mesenchymal stem/stromal cells. J Equine Sci 2023 Sep;34(3):67-72.
              doi: 10.1294/jes.34.67pubmed: 37781569google scholar: lookup
            15. Koch DW, Schnabel LV. Mesenchymal stem cell licensing: enhancing MSC function as a translational approach for the treatment of tendon injury. Am J Vet Res 2023 Sep 1;84(10):1-8.
              doi: 10.2460/ajvr.23.07.0154pubmed: 37669745google scholar: lookup
            16. Soukup R, Gerner I, Mohr T, Gueltekin S, Grillari J, Jenner F. Mesenchymal Stem Cell Conditioned Medium Modulates Inflammation in Tenocytes: Complete Conditioned Medium Has Superior Therapeutic Efficacy than Its Extracellular Vesicle Fraction. Int J Mol Sci 2023 Jun 29;24(13).
              doi: 10.3390/ijms241310857pubmed: 37446034google scholar: lookup
            17. Jiang L, Lu J, Chen Y, Lyu K, Long L, Wang X, Liu T, Li S. Mesenchymal stem cells: An efficient cell therapy for tendon repair (Review). Int J Mol Med 2023 Aug;52(2).
              doi: 10.3892/ijmm.2023.5273pubmed: 37387410google scholar: lookup
            18. Miquel J, Salomó-Domènech M, Santana F, Torrens C. Impact of surrogate outcomes in randomized controlled trials for shoulder rotator cuff tears. Arch Orthop Trauma Surg 2023 Oct;143(10):6117-6122.
              doi: 10.1007/s00402-023-04911-0pubmed: 37219598google scholar: lookup
            19. Quintero D, Perucca Orfei C, Kaplan LD, de Girolamo L, Best TM, Kouroupis D. The roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies. Front Bioeng Biotechnol 2023;11:1040762.
              doi: 10.3389/fbioe.2023.1040762pubmed: 36741745google scholar: lookup
            20. Smith EJ, Beaumont RE, McClellan A, Sze C, Palomino Lago E, Hazelgrove L, Dudhia J, Smith RKW, Guest DJ. Tumour necrosis factor alpha, interleukin 1 beta and interferon gamma have detrimental effects on equine tenocytes that cannot be rescued by IL-1RA or mesenchymal stromal cell-derived factors. Cell Tissue Res 2023 Mar;391(3):523-544.
              doi: 10.1007/s00441-022-03726-6pubmed: 36543895google scholar: lookup
            21. El-Husseiny HM, Mady EA, Helal MAY, Tanaka R. The Pivotal Role of Stem Cells in Veterinary Regenerative Medicine and Tissue Engineering. Vet Sci 2022 Nov 21;9(11).
              doi: 10.3390/vetsci9110648pubmed: 36423096google scholar: lookup
            22. Supokawej A, Korchunjit W, Wongtawan T. The combination of BMP12 and KY02111 enhances tendon differentiation in bone marrow-derived equine mesenchymal stromal cells (BM-eMSCs). J Equine Sci 2022 Jul;33(2):19-26.
              doi: 10.1294/jes.33.19pubmed: 35847484google scholar: lookup
            23. Voga M, Majdic G. Articular Cartilage Regeneration in Veterinary Medicine. Adv Exp Med Biol 2022;1401:23-55.
              doi: 10.1007/5584_2022_717pubmed: 35733035google scholar: lookup
            24. Mollichella ML, Mechin V, Royer D, Pageat P, Asproni P. Isolation and Characterization of Cat Olfactory Ecto-Mesenchymal Stem Cells. Animals (Basel) 2022 May 17;12(10).
              doi: 10.3390/ani12101284pubmed: 35625130google scholar: lookup
            25. Roth SP, Burk J, Brehm W, Troillet A. MSC in Tendon and Joint Disease: The Context-Sensitive Link Between Targets and Therapeutic Mechanisms. Front Bioeng Biotechnol 2022;10:855095.
              doi: 10.3389/fbioe.2022.855095pubmed: 35445006google scholar: lookup
            26. Viganò M, Ragni E, Marmotti A, de Girolamo L. The effects of orthobiologics in the treatment of tendon pathologies: a systematic review of preclinical evidence. J Exp Orthop 2022 Apr 8;9(1):31.
              doi: 10.1186/s40634-022-00468-wpubmed: 35394237google scholar: lookup
            27. Knott LE, Fonseca-Martinez BA, O'Connor AM, Goodrich LR, McIlwraith CW, Colbath AC. Current use of biologic therapies for musculoskeletal disease: A survey of board-certified equine specialists. Vet Surg 2022 May;51(4):557-567.
              doi: 10.1111/vsu.13805pubmed: 35383972google scholar: lookup
            28. Depuydt E, Broeckx SY, Chiers K, Patruno M, Da Dalt L, Duchateau L, Saunders J, Pille F, Martens A, Van Hecke L, Spaas JH. Cellular and Humoral Immunogenicity Investigation of Single and Repeated Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering From Tendon Injuries. Front Vet Sci 2021;8:789293.
              doi: 10.3389/fvets.2021.789293pubmed: 35281431google scholar: lookup
            29. Hagen A, Holland H, Brandt VP, Doll CU, Häußler TC, Melzer M, Moellerberndt J, Lehmann H, Burk J. Platelet Lysate for Mesenchymal Stromal Cell Culture in the Canine and Equine Species: Analogous but Not the Same. Animals (Basel) 2022 Jan 13;12(2).
              doi: 10.3390/ani12020189pubmed: 35049811google scholar: lookup
            30. Doll CU, Niebert S, Burk J. Mesenchymal Stromal Cells Adapt to Chronic Tendon Disease Environment with an Initial Reduction in Matrix Remodeling. Int J Mol Sci 2021 Nov 26;22(23).
              doi: 10.3390/ijms222312798pubmed: 34884602google scholar: lookup
            31. Hafeez MN, d'Avanzo N, Russo V, Di Marzio L, Cilurzo F, Paolino D, Fresta M, Barboni B, Santos HA, Celia C. Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds. Stem Cells Int 2021;2021:1488829.
              doi: 10.1155/2021/1488829pubmed: 34824586google scholar: lookup
            32. Hotham WE, Thompson C, Szu-Ting L, Henson FMD. The anti-inflammatory effects of equine bone marrow stem cell-derived extracellular vesicles on autologous chondrocytes. Vet Rec Open 2021 Dec;8(1):e22.
              doi: 10.1002/vro2.22pubmed: 34795904google scholar: lookup
            33. Melzer M, Schubert S, Müller SF, Geyer J, Hagen A, Niebert S, Burk J. Rho/ROCK Inhibition Promotes TGF-β3-Induced Tenogenic Differentiation in Mesenchymal Stromal Cells. Stem Cells Int 2021;2021:8284690.
              doi: 10.1155/2021/8284690pubmed: 34659420google scholar: lookup
            34. Prządka P, Buczak K, Frejlich E, Gąsior L, Suliga K, Kiełbowicz Z. The Role of Mesenchymal Stem Cells (MSCs) in Veterinary Medicine and Their Use in Musculoskeletal Disorders. Biomolecules 2021 Aug 2;11(8).
              doi: 10.3390/biom11081141pubmed: 34439807google scholar: lookup
            35. Menarim BC, MacLeod JN, Dahlgren LA. Bone marrow mononuclear cells for joint therapy: The role of macrophages in inflammation resolution and tissue repair. World J Stem Cells 2021 Jul 26;13(7):825-840.
              doi: 10.4252/wjsc.v13.i7.825pubmed: 34367479google scholar: lookup
            36. Gaesser AM, Underwood C, Linardi RL, Even KM, Reef VB, Shetye SS, Mauck RL, King WJ, Engiles JB, Ortved KF. Evaluation of Autologous Protein Solution Injection for Treatment of Superficial Digital Flexor Tendonitis in an Equine Model. Front Vet Sci 2021;8:697551.
              doi: 10.3389/fvets.2021.697551pubmed: 34291103google scholar: lookup
            37. Mocchi M, Grolli S, Dotti S, Di Silvestre D, Villa R, Berni P, Conti V, Passignani G, Brambilla F, Bue MD, Catenacci L, Sorrenti M, Segale L, Bari E, Mauri P, Torre ML, Perteghella S. Equine Mesenchymal Stem/Stromal Cells Freeze-Dried Secretome (Lyosecretome) for the Treatment of Musculoskeletal Diseases: Production Process Validation and Batch Release Test for Clinical Use. Pharmaceuticals (Basel) 2021 Jun 10;14(6).
              doi: 10.3390/ph14060553pubmed: 34200627google scholar: lookup
            38. Meeremans M, Van de Walle GR, Van Vlierberghe S, De Schauwer C. The Lack of a Representative Tendinopathy Model Hampers Fundamental Mesenchymal Stem Cell Research. Front Cell Dev Biol 2021;9:651164.
              doi: 10.3389/fcell.2021.651164pubmed: 34012963google scholar: lookup
            39. Depuydt E, Broeckx SY, Van Hecke L, Chiers K, Van Brantegem L, van Schie H, Beerts C, Spaas JH, Pille F, Martens A. The Evaluation of Equine Allogeneic Tenogenic Primed Mesenchymal Stem Cells in a Surgically Induced Superficial Digital Flexor Tendon Lesion Model. Front Vet Sci 2021;8:641441.
              doi: 10.3389/fvets.2021.641441pubmed: 33748217google scholar: lookup
            40. Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases. Animals (Basel) 2021 Jan 19;11(1).
              doi: 10.3390/ani11010234pubmed: 33477808google scholar: lookup
            41. Chung MJ, Son JY, Park S, Park SS, Hur K, Lee SH, Lee EJ, Park JK, Hong IH, Kim TH, Jeong KS. Mesenchymal Stem Cell and MicroRNA Therapy of Musculoskeletal Diseases. Int J Stem Cells 2021 May 30;14(2):150-167.
              doi: 10.15283/ijsc20167pubmed: 33377459google scholar: lookup
            42. Ribitsch I, Baptista PM, Lange-Consiglio A, Melotti L, Patruno M, Jenner F, Schnabl-Feichter E, Dutton LC, Connolly DJ, van Steenbeek FG, Dudhia J, Penning LC. Large Animal Models in Regenerative Medicine and Tissue Engineering: To Do or Not to Do. Front Bioeng Biotechnol 2020;8:972.
              doi: 10.3389/fbioe.2020.00972pubmed: 32903631google scholar: lookup
            43. Ciardulli MC, Marino L, Lamparelli EP, Guida M, Forsyth NR, Selleri C, Della Porta G, Maffulli N. Dose-Response Tendon-Specific Markers Induction by Growth Differentiation Factor-5 in Human Bone Marrow and Umbilical Cord Mesenchymal Stem Cells. Int J Mol Sci 2020 Aug 17;21(16).
              doi: 10.3390/ijms21165905pubmed: 32824547google scholar: lookup
            44. Voga M, Adamic N, Vengust M, Majdic G. Stem Cells in Veterinary Medicine-Current State and Treatment Options. Front Vet Sci 2020;7:278.
              doi: 10.3389/fvets.2020.00278pubmed: 32656249google scholar: lookup
            45. Mocchi M, Dotti S, Bue MD, Villa R, Bari E, Perteghella S, Torre ML, Grolli S. Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?. Cells 2020 Jun 11;9(6).
              doi: 10.3390/cells9061453pubmed: 32545382google scholar: lookup
            46. Horstmeier C, Ahrberg AB, Berner D, Burk J, Gittel C, Hillmann A, Offhaus J, Brehm W. In Vivo Magic Angle Magnetic Resonance Imaging for Cell Tracking in Equine Low-Field MRI. Stem Cells Int 2019;2019:5670106.
              doi: 10.1155/2019/5670106pubmed: 31933650google scholar: lookup
            47. Colbath AC, Dow SW, Hopkins LS, Phillips JN, McIlwraith CW, Goodrich LR. Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis. Equine Vet J 2020 Jul;52(4):601-612.
              doi: 10.1111/evj.13222pubmed: 31821594google scholar: lookup
            48. Khan MR, Smith RK, David F, Lam R, Hughes G, De Godoy R, Carr AJ, Goodship AE, Dudhia J. Evaluation of the Effects of Synovial Multipotent Cells on Deep Digital Flexor Tendon Repair in a Large Animal Model of Intra-Synovial Tendinopathy. J Orthop Res 2020 Jan;38(1):128-138.
              doi: 10.1002/jor.24423pubmed: 31329308google scholar: lookup
            49. Lamas JR, García-Fernández C, Tornero-Esteban P, Lópiz Y, Rodriguez-Rodriguez L, Ortega L, Fernández-Gutiérrez B, Marco F. Adverse effects of xenogenic scaffolding in the context of a randomized double-blind placebo-controlled study for repairing full-thickness rotator cuff tears. Trials 2019 Jul 1;20(1):387.
              doi: 10.1186/s13063-019-3504-3pubmed: 31262366google scholar: lookup
            50. Rajpar I, Barrett JG. Optimizing growth factor induction of tenogenesis in three-dimensional culture of mesenchymal stem cells. J Tissue Eng 2019 Jan-Dec;10:2041731419848776.
              doi: 10.1177/2041731419848776pubmed: 31205672google scholar: lookup
            51. Kornicka K, Geburek F, Röcken M, Marycz K. Stem Cells in Equine Veterinary Practice-Current Trends, Risks, and Perspectives. J Clin Med 2019 May 14;8(5).
              doi: 10.3390/jcm8050675pubmed: 31091732google scholar: lookup
            52. Perucca Orfei C, Viganò M, Pearson JR, Colombini A, De Luca P, Ragni E, Santos-Ruiz L, de Girolamo L. In Vitro Induction of Tendon-Specific Markers in Tendon Cells, Adipose- and Bone Marrow-Derived Stem Cells is Dependent on TGFβ3, BMP-12 and Ascorbic Acid Stimulation. Int J Mol Sci 2019 Jan 3;20(1).
              doi: 10.3390/ijms20010149pubmed: 30609804google scholar: lookup
            53. Grady ST, Britton L, Hinrichs K, Nixon AJ, Watts AE. Persistence of fluorescent nanoparticle-labelled bone marrow mesenchymal stem cells in vitro and after intra-articular injection. J Tissue Eng Regen Med 2019 Feb;13(2):191-202.
              doi: 10.1002/term.2781pubmed: 30536848google scholar: lookup
            54. Moro LN, Amin G, Furmento V, Waisman A, Garate X, Neiman G, La Greca A, Santín Velazque NL, Luzzani C, Sevlever GE, Vichera G, Miriuka SG. MicroRNA characterization in equine induced pluripotent stem cells. PLoS One 2018;13(12):e0207074.
              doi: 10.1371/journal.pone.0207074pubmed: 30507934google scholar: lookup
            55. Roth SP, Schubert S, Scheibe P, Groß C, Brehm W, Burk J. Growth Factor-Mediated Tenogenic Induction of Multipotent Mesenchymal Stromal Cells Is Altered by the Microenvironment of Tendon Matrix. Cell Transplant 2018 Oct;27(10):1434-1450.
              doi: 10.1177/0963689718792203pubmed: 30251565google scholar: lookup
            56. Abat F, Alfredson H, Cucchiarini M, Madry H, Marmotti A, Mouton C, Oliveira JM, Pereira H, Peretti GM, Spang C, Stephen J, van Bergen CJA, de Girolamo L. Current trends in tendinopathy: consensus of the ESSKA basic science committee. Part II: treatment options. J Exp Orthop 2018 Sep 24;5(1):38.
              doi: 10.1186/s40634-018-0145-5pubmed: 30251203google scholar: lookup
            57. Kennedy MI, Whitney K, Evans T, LaPrade RF. Platelet-Rich Plasma and Cartilage Repair. Curr Rev Musculoskelet Med 2018 Dec;11(4):573-582.
              doi: 10.1007/s12178-018-9516-xpubmed: 30203333google scholar: lookup
            58. Brandt L, Schubert S, Scheibe P, Brehm W, Franzen J, Gross C, Burk J. Tenogenic Properties of Mesenchymal Progenitor Cells Are Compromised in an Inflammatory Environment. Int J Mol Sci 2018 Aug 28;19(9).
              doi: 10.3390/ijms19092549pubmed: 30154348google scholar: lookup
            59. Winter RL, Seeto WJ, Tian Y, Caldwell FJ, Lipke EA, Wooldridge AA. Growth and function of equine endothelial colony forming cells labeled with semiconductor quantum dots. BMC Vet Res 2018 Aug 23;14(1):247.
              doi: 10.1186/s12917-018-1572-3pubmed: 30139355google scholar: lookup
            60. Ahrberg AB, Horstmeier C, Berner D, Brehm W, Gittel C, Hillmann A, Josten C, Rossi G, Schubert S, Winter K, Burk J. Effects of mesenchymal stromal cells versus serum on tendon healing in a controlled experimental trial in an equine model. BMC Musculoskelet Disord 2018 Jul 18;19(1):230.
              doi: 10.1186/s12891-018-2163-ypubmed: 30021608google scholar: lookup
            61. Khan MR, Dudhia J, David FH, De Godoy R, Mehra V, Hughes G, Dakin SG, Carr AJ, Goodship AE, Smith RKW. Bone marrow mesenchymal stem cells do not enhance intra-synovial tendon healing despite engraftment and homing to niches within the synovium. Stem Cell Res Ther 2018 Jun 19;9(1):169.
              doi: 10.1186/s13287-018-0900-7pubmed: 29921317google scholar: lookup
            62. Goldberg AJ, Zaidi R, Brooking D, Kim L, Korda M, Masci L, Green R, O'Donnell P, Smith R. Autologous Stem Cells in Achilles Tendinopathy (ASCAT): protocol for a phase IIA, single-centre, proof-of-concept study. BMJ Open 2018 May 14;8(5):e021600.
              doi: 10.1136/bmjopen-2018-021600pubmed: 29764889google scholar: lookup
            63. Wagner JR, Taguchi T, Cho JY, Charavaryamath C, Griffon DJ. Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats. J Vis Exp 2018 Mar 30;(133).
              doi: 10.3791/56810pubmed: 29658926google scholar: lookup
            64. Cassano JM, Schnabel LV, Goodale MB, Fortier LA. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment. Stem Cell Res Ther 2018 Apr 3;9(1):82.
              doi: 10.1186/s13287-018-0840-2pubmed: 29615127google scholar: lookup
            65. Jacquet-Guibon S, Dupays AG, Coudry V, Crevier-Denoix N, Leroy S, Siñeriz F, Chiappini F, Barritault D, Denoix JM. Randomized controlled trial demonstrates the benefit of RGTA® based matrix therapy to treat tendinopathies in racing horses. PLoS One 2018;13(3):e0191796.
              doi: 10.1371/journal.pone.0191796pubmed: 29522564google scholar: lookup
            66. Olivera R, Moro LN, Jordan R, Pallarols N, Guglielminetti A, Luzzani C, Miriuka SG, Vichera G. Bone marrow mesenchymal stem cells as nuclear donors improve viability and health of cloned horses. Stem Cells Cloning 2018;11:13-22.
              doi: 10.2147/SCCAA.S151763pubmed: 29497320google scholar: lookup
            67. Schröck C, Eydt C, Geburek F, Kaiser L, Päbst F, Burk J, Pfarrer C, Staszyk C. Bone marrow-derived multipotent mesenchymal stromal cells from horses after euthanasia. Vet Med Sci 2017 Nov;3(4):239-251.
              doi: 10.1002/vms3.74pubmed: 29152317google scholar: lookup
            68. Eydt C, Geburek F, Schröck C, Hambruch N, Rohn K, Pfarrer C, Staszyk C. Sternal bone marrow derived equine multipotent mesenchymal stromal cells (MSCs): investigations considering the sampling site and the use of different culture media. Vet Med Sci 2016 Aug;2(3):200-210.
              doi: 10.1002/vms3.36pubmed: 29067195google scholar: lookup
            69. Textor JA, Clark KC, Walker NJ, Aristizobal FA, Kol A, LeJeune SS, Bledsoe A, Davidyan A, Gray SN, Bohannon-Worsley LK, Woolard KD, Borjesson DL. Allogeneic Stem Cells Alter Gene Expression and Improve Healing of Distal Limb Wounds in Horses. Stem Cells Transl Med 2018 Jan;7(1):98-108.
              doi: 10.1002/sctm.17-0071pubmed: 29063737google scholar: lookup
            70. Beerts C, Suls M, Broeckx SY, Seys B, Vandenberghe A, Declercq J, Duchateau L, Vidal MA, Spaas JH. Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses. Front Vet Sci 2017;4:158.
              doi: 10.3389/fvets.2017.00158pubmed: 29018808google scholar: lookup
            71. Watts AE, Millar NL, Platt J, Kitson SM, Akbar M, Rech R, Griffin J, Pool R, Hughes T, McInnes IB, Gilchrist DS. MicroRNA29a Treatment Improves Early Tendon Injury. Mol Ther 2017 Oct 4;25(10):2415-2426.
              doi: 10.1016/j.ymthe.2017.07.015pubmed: 28822690google scholar: lookup
            72. Zhu J, Meng P, Wang Q, Wang H, Zhang J, Li Y, Li D, Tan X, Yang L, Huang J. Effects of neuritin on the differentiation of bone marrow‑derived mesenchymal stem cells into neuron‑like cells. Mol Med Rep 2017 Sep;16(3):3201-3207.
              doi: 10.3892/mmr.2017.6987pubmed: 28714031google scholar: lookup
            73. Geburek F, Roggel F, van Schie HTM, Beineke A, Estrada R, Weber K, Hellige M, Rohn K, Jagodzinski M, Welke B, Hurschler C, Conrad S, Skutella T, van de Lest C, van Weeren R, Stadler PM. Effect of single intralesional treatment of surgically induced equine superficial digital flexor tendon core lesions with adipose-derived mesenchymal stromal cells: a controlled experimental trial. Stem Cell Res Ther 2017 Jun 5;8(1):129.
              doi: 10.1186/s13287-017-0564-8pubmed: 28583184google scholar: lookup
            74. Rubio-Azpeitia E, Sánchez P, Delgado D, Andia I. Adult Cells Combined With Platelet-Rich Plasma for Tendon Healing: Cell Source Options. Orthop J Sports Med 2017 Feb;5(2):2325967117690846.
              doi: 10.1177/2325967117690846pubmed: 28321425google scholar: lookup
            75. Kim SJ, Song DH, Park JW, Park S, Kim SJ. Effect of Bone Marrow Aspirate Concentrate-Platelet-Rich Plasma on Tendon-Derived Stem Cells and Rotator Cuff Tendon Tear. Cell Transplant 2017 May 9;26(5):867-878.
              doi: 10.3727/096368917X694705pubmed: 28105983google scholar: lookup
            76. Scharf A, Holmes SP, Thoresen M, Mumaw J, Stumpf A, Peroni J. MRI-Based Assessment of Intralesional Delivery of Bone Marrow-Derived Mesenchymal Stem Cells in a Model of Equine Tendonitis. Stem Cells Int 2016;2016:8610964.
              doi: 10.1155/2016/8610964pubmed: 27746821google scholar: lookup
            77. Burk J, Plenge A, Brehm W, Heller S, Pfeiffer B, Kasper C. Induction of Tenogenic Differentiation Mediated by Extracellular Tendon Matrix and Short-Term Cyclic Stretching. Stem Cells Int 2016;2016:7342379.
              doi: 10.1155/2016/7342379pubmed: 27630718google scholar: lookup
            78. Walden G, Liao X, Donell S, Raxworthy MJ, Riley GP, Saeed A. A Clinical, Biological, and Biomaterials Perspective into Tendon Injuries and Regeneration. Tissue Eng Part B Rev 2017 Feb;23(1):44-58.
              doi: 10.1089/ten.TEB.2016.0181pubmed: 27596929google scholar: lookup
            79. Markoski MM. Advances in the Use of Stem Cells in Veterinary Medicine: From Basic Research to Clinical Practice. Scientifica (Cairo) 2016;2016:4516920.
              doi: 10.1155/2016/4516920pubmed: 27379197google scholar: lookup
            80. Griffon DJ, Cho J, Wagner JR, Charavaryamath C, Wei J, Wagoner Johnson A. Effects of Hypoxia and Chitosan on Equine Umbilical Cord-Derived Mesenchymal Stem Cells. Stem Cells Int 2016;2016:2987140.
              doi: 10.1155/2016/2987140pubmed: 27379167google scholar: lookup
            81. Somal A, Bhat IA, B I, Pandey S, Panda BS, Thakur N, Sarkar M, Chandra V, Saikumar G, Sharma GT. A Comparative Study of Growth Kinetics, In Vitro Differentiation Potential and Molecular Characterization of Fetal Adnexa Derived Caprine Mesenchymal Stem Cells. PLoS One 2016;11(6):e0156821.
              doi: 10.1371/journal.pone.0156821pubmed: 27257959google scholar: lookup
            82. Espina M, Jülke H, Brehm W, Ribitsch I, Winter K, Delling U. Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses. PeerJ 2016;4:e1773.
              doi: 10.7717/peerj.1773pubmed: 27019778google scholar: lookup
            83. Leone L, Raffa S, Vetrano M, Ranieri D, Malisan F, Scrofani C, Vulpiani MC, Ferretti A, Torrisi MR, Visco V. Extracorporeal Shock Wave Treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs). Oncotarget 2016 Feb 9;7(6):6410-23.
              doi: 10.18632/oncotarget.7064pubmed: 26843618google scholar: lookup
            84. Geburek F, Mundle K, Conrad S, Hellige M, Walliser U, van Schie HT, van Weeren R, Skutella T, Stadler PM. Tracking of autologous adipose tissue-derived mesenchymal stromal cells with in vivo magnetic resonance imaging and histology after intralesional treatment of artificial equine tendon lesions--a pilot study. Stem Cell Res Ther 2016 Feb 1;7:21.
              doi: 10.1186/s13287-016-0281-8pubmed: 26830812google scholar: lookup
            85. Gomiero C, Bertolutti G, Martinello T, Van Bruaene N, Broeckx SY, Patruno M, Spaas JH. Tenogenic induction of equine mesenchymal stem cells by means of growth factors and low-level laser technology. Vet Res Commun 2016 Mar;40(1):39-48.
              doi: 10.1007/s11259-016-9652-ypubmed: 26757735google scholar: lookup
            86. Sayegh ET, Sandy JD, Virk MS, Romeo AA, Wysocki RW, Galante JO, Trella KJ, Plaas A, Wang VM. Recent Scientific Advances Towards the Development of Tendon Healing Strategies. Curr Tissue Eng 2015;4(2):128-143.
              doi: 10.2174/2211542004666150713190231pubmed: 26753125google scholar: lookup
            87. Dudhia J, Becerra P, Valdés MA, Neves F, Hartman NG, Smith RK. In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy. J Vis Exp 2015 Dec 9;(106):e52748.
              doi: 10.3791/52748pubmed: 26709915google scholar: lookup
            88. Ekwueme EC, Shah JV, Mohiuddin M, Ghebes CA, Crispim JF, Saris DB, Fernandes HA, Freeman JW. Cross-Talk Between Human Tenocytes and Bone Marrow Stromal Cells Potentiates Extracellular Matrix Remodeling In Vitro. J Cell Biochem 2016 Mar;117(3):684-93.
              doi: 10.1002/jcb.25353pubmed: 26308651google scholar: lookup
            89. Atesok K, Fu FH, Sekiya I, Stolzing A, Ochi M, Rodeo SA. Stem cells in degenerative orthopaedic pathologies: effects of aging on therapeutic potential. Knee Surg Sports Traumatol Arthrosc 2017 Feb;25(2):626-636.
              doi: 10.1007/s00167-015-3763-9pubmed: 26298714google scholar: lookup
            90. Geburek F, Lietzau M, Beineke A, Rohn K, Stadler PM. Effect of a single injection of autologous conditioned serum (ACS) on tendon healing in equine naturally occurring tendinopathies. Stem Cell Res Ther 2015 Jun 26;6(1):126.
              doi: 10.1186/s13287-015-0115-0pubmed: 26113022google scholar: lookup
            91. Muttini A, Russo V, Rossi E, Mattioli M, Barboni B, Tosi U, Maffulli N, Valbonetti L, Abate M. Pilot experimental study on amniotic epithelial mesenchymal cell transplantation in natural occurring tendinopathy in horses. Ultrasonographic and histological comparison. Muscles Ligaments Tendons J 2015 Jan-Mar;5(1):5-11.
              pubmed: 25878980
            92. Lavagnino M, Wall ME, Little D, Banes AJ, Guilak F, Arnoczky SP. Tendon mechanobiology: Current knowledge and future research opportunities. J Orthop Res 2015 Jun;33(6):813-22.
              doi: 10.1002/jor.22871pubmed: 25763779google scholar: lookup
            93. Tian F, Ji XL, Xiao WA, Wang B, Wang F. CXCL13 promotes the effect of bone marrow mesenchymal stem cells (MSCs) on tendon-bone healing in rats and in C3HIOT1/2 cells. Int J Mol Sci 2015 Jan 30;16(2):3178-87.
              doi: 10.3390/ijms16023178pubmed: 25647417google scholar: lookup
            94. Docheva D, Müller SA, Majewski M, Evans CH. Biologics for tendon repair. Adv Drug Deliv Rev 2015 Apr;84:222-39.
              doi: 10.1016/j.addr.2014.11.015pubmed: 25446135google scholar: lookup
            95. Garvican ER, Cree S, Bull L, Smith RK, Dudhia J. Viability of equine mesenchymal stem cells during transport and implantation. Stem Cell Res Ther 2014 Aug 8;5(4):94.
              doi: 10.1186/scrt483pubmed: 25107289google scholar: lookup
            Subscribe to our newsletter
            Join 99,001 horse owners like you who receive our email updates on horse health and nutrition.